Ally Bridge Group as of March 31, 2024
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 22 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 8.5 | $15M | 161k | 94.86 | |
| Soleno Therapeutics (SLNO) | 8.0 | $14M | 337k | 42.80 | |
| Cg Oncology (CGON) | 7.8 | $14M | 320k | 43.90 | |
| Xenon Pharmaceuticals (XENE) | 7.4 | $13M | 309k | 43.05 | |
| Verona Pharma Sponsored Ads (VRNA) | 6.6 | $12M | 737k | 16.09 | |
| Merus N V (MRUS) | 6.4 | $12M | 256k | 45.03 | |
| Praxis Precision Medicines I (PRAX) | 5.4 | $9.7M | 160k | 61.02 | |
| Mind Medicine Mindmed Com New (MNMD) | 5.2 | $9.4M | 1.0M | 9.40 | |
| Avadel Pharmaceuticals Sponsored Adr | 5.1 | $9.2M | 547k | 16.89 | |
| Geron Corporation (GERN) | 5.1 | $9.1M | 2.8M | 3.30 | |
| Jasper Therapeutics Com New (JSPR) | 4.7 | $8.5M | 290k | 29.36 | |
| Kura Oncology (KURA) | 4.3 | $7.8M | 365k | 21.33 | |
| Insmed Com Par $.01 (INSM) | 3.8 | $6.8M | 250k | 27.13 | |
| Dianthus Therapeutics (DNTH) | 3.6 | $6.5M | 217k | 30.00 | |
| Olema Pharmaceuticals (OLMA) | 3.5 | $6.3M | 559k | 11.32 | |
| Lyra Therapeutics (LYRA) | 3.5 | $6.2M | 1.0M | 6.22 | |
| Longboard Pharmaceuticals In (LBPH) | 3.2 | $5.8M | 271k | 21.60 | |
| Rapt Therapeutics (RAPT) | 2.1 | $3.8M | 420k | 8.98 | |
| Mersana Therapeutics (MRSN) | 2.0 | $3.6M | 801k | 4.48 | |
| Marinus Pharmaceuticals Com New (MRNS) | 2.0 | $3.6M | 395k | 9.04 | |
| Promis Neurosciences Com New (PMN) | 1.1 | $2.0M | 1.1M | 1.91 | |
| Context Therapeutics (CNTX) | 0.6 | $1.0M | 726k | 1.38 |
